Form 4: Modular Medical Executive Receives Stock Option Grant

Paul DiPerna, Chairman, President, and CFO of Modular Medical, was granted 11,218 stock options.

Summary

• Paul DiPerna, serving as Chairman, President, CFO, and Treasurer, received a grant of 11,218 stock options.
• The options have an exercise price of $3.46 per share.
• The grant was issued on May 14, 2026, with an expiration date of May 14, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation that carries no significant market-moving sentiment.

Positives

• Aligns executive compensation with long-term shareholder value through equity-based incentives.

Negatives

• The grant results in potential future dilution for existing shareholders upon exercise.

Risks

• Market volatility affecting the value of the underlying common stock relative to the $3.46 exercise price.

Future Outlook

The options vest over a three-year period, with 1/3rd vesting on May 14, 2027, and the remainder vesting monthly thereafter.

Management Comments

• The filing does not contain narrative management commentary.

Industry Context

StockSavvy.ai notes that equity grants to C-suite executives are standard practice in the medical device sector to ensure leadership retention and alignment with corporate performance milestones.

Comparison to Industry Standards

• The vesting schedule of 1/3rd after one year followed by monthly vesting is consistent with standard industry practices for executive equity compensation.

Stakeholder Impact

• Minor dilution impact on existing shareholders upon future exercise of options.

Next Steps

• Vesting of the first tranche of options on May 14, 2027.

Key Dates

Keywords

Modular Medical, MODD, Form 4, Stock Options, Executive Compensation, Insider Transaction